Clinical trial
MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)
NCT00266344 · H. Lundbeck A/S, Industry · Completed
Key facts
| NCT number | NCT00266344 |
|---|---|
| Title | MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED) |
| Official title | MK0928 Phase IIb Dose-range Finding Study -Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Primary Insomnia |
| Intervention type | Drug |
| Interventions | MK0928, gaboxadol / Duration of Treatment 3 Weeks, Placebo / Duration of Treatment 3 Weeks |
| Enrollment | 520 |
| Start date | Nov 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Dec 16, 2005 |
| Last update posted | Jan 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: